此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Transitional Case Management Study

2016年11月16日 更新者:University of California, Los Angeles
To address the issues involved in treatment participation by substance-abusing parolees, the CJ-DATS Transitional Case Management (TCM) study proposes to test a parole re-entry model that consists of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone case conference call that includes the inmate and significant members of the inmate's aftercare plan (including the parole officer), and (3) strengths case management (for 12 weeks) in the community to promote treatment participation and support the client's access to needed services.

研究概览

详细说明

To address the issues involved in treatment participation by substance-abusing parolees, the CJ-DATS Transitional Case Management (TCM) study proposes to test a parole re-entry model that consists of (1) completion by the inmate of a strengths and goals assessment as part of discharge planning, (2) a telephone case conference call that includes the inmate and significant members of the inmate's aftercare plan (including the parole officer), and (3) strengths case management (for 12 weeks) in the community to promote treatment participation and support the client's access to needed services.

More specifically, the multi-site study will evaluate the effects of a strengths case-management intervention on community-based treatment/service admission, retention, and utilization among inmates released from supervised treatment programs. If the intervention is successful, its wider adoption would increase the likelihood that inmates enter and remain in community services.

The specific aims of this multi-site study are to:

  1. Increase the likelihood that offenders leaving prison (or other supervised setting) with a referral to community aftercare program services enroll in treatment.
  2. Increase the amount of time that such offenders participate in community treatment.
  3. Assist clients to get the services that they need during the first 12 weeks of return to the community.
  4. As a result of the above, reduce relapse and reoffending during and following treatment.
  5. Achieve the above results at a favorable cost-effectiveness ratio.
  6. Encourage closer collaboration between the treatment and criminal justice systems.

Study participants (200 at each site, 25% of will be women) will be recruited in prison (or other confined setting) from inmates who have a referral to community treatment. After informed consent and a baseline interview, they will be randomly assigned to one of two conditions: (1) the Transitional Case Management condition, and (2) the Standard Referral condition (i.e., usual transition/re-entry procedures used by the facility, including a referral to community treatment).

Individual-level outcomes will include (1) treatment admission and participation (based on data collected from programs), (2) drug use, criminal activity, and psychosocial functioning (based on telephone interviews conducted 3 months after the end of the intervention) and (3) recidivism (based on records collected 12 months after the end of the intervention). The study will also assess the impact of the intervention on organizational and system factors (based on information from the case manager, treatment staff, and criminal justice staff) and the cost effectiveness of the intervention.

研究类型

介入性

注册 (实际的)

812

阶段

  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • California
      • Los Angeles、California、美国、90025
        • University of California, Los Angeles
    • Connecticut
      • Hartford、Connecticut、美国、06134
        • Connecticut Department of Mental Health and Addiction Services
    • Kentucky
      • Lexington、Kentucky、美国、40506
        • University of Kentucky
    • New York
      • New York、New York、美国、10048
        • National Development and Research Institutes, Inc. (NDRI)

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Age 18 years or older
  • Participate in a treatment program within a correctional institution (prison, work release, community correctional facility)
  • Have a referral to a community-based substance abuse treatment program (as arranged by correctional staff or treatment staff)
  • Within about 3 months until release
  • Being released to the metropolitan area where case manager activities are being conducted

Exclusion Criteria:

  • Referral to formal case management services in the community (e.g., for offenders with co-occurring disorders)
  • Inability to provide informed consent (as determined by a set of questions about the consent process)
  • Registered sex offender (as determined by the institution)
  • Parole requirements that would prevent participation in the study (e.g., INS hold for deportation)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Treatment admission by three months following parole
大体时间:Three months
Three months
Treatment retention by three months following parole
大体时间:Three months
Three months
Drug use at nine months following parole
大体时间:Nine months
Nine months
Recidivism at nine months following parole
大体时间:Nine months
Nine months

次要结果测量

结果测量
大体时间
Education and employment at nine months following parole
大体时间:Nine months
Nine months
HIV risk behaviors at nine months following parole
大体时间:Nine months
Nine months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Michael L Prendergast, Ph.D.、University of California, Los Angeles
  • 研究主任:Jerome Cartier, M.S.、University of California, Los Angeles

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2004年11月1日

初级完成 (实际的)

2006年4月1日

研究完成 (实际的)

2008年5月1日

研究注册日期

首次提交

2005年12月8日

首先提交符合 QC 标准的

2005年12月8日

首次发布 (估计)

2005年12月12日

研究记录更新

最后更新发布 (估计)

2016年11月18日

上次提交的符合 QC 标准的更新

2016年11月16日

最后验证

2016年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • U01DA016211 (美国 NIH 拨款/合同)

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅